Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Cyclerion Therapeutics, Inc.”

17 pharma patents match "Cyclerion Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 17
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 17 pharmaceutical patents matching "Cyclerion Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

17 results for “Cyclerion Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12247025

    Processes for preparation of soluble guanylate cyclase stimulators

    Cyclerion Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  2. US 11834444

    Processes for preparation of soluble guanylate cyclase stimulators

    Cyclerion Therapeutics, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  3. US 11731977

    SGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  4. US 11690828

    Treatment of CNS diseases with sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  5. US 11572358

    Solid forms of an sGC stimulator

    Cyclerion Therapeutics, Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  6. US 11466015

    Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  7. US 11389449

    Treatment of metabolic syndrome with an sGC stimulator

    Cyclerion Therapeutics, Inc. · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  8. US 11357777

    Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

    Cyclerion Therapeutics, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  9. US 11207323

    sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  10. US 11180493

    SGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  11. US 10927136

    Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  12. US 10889577

    Solid forms of an sGC stimulator

    Cyclerion Therapeutics, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  13. US 10858363

    SGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  14. US 10844064

    sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  15. US 10639308

    sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  16. US 10517874

    sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  17. US 10472363

    SGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted